Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001039328 | SCV001202855 | uncertain significance | Ehlers-Danlos syndrome, type 4 | 2019-12-27 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with COL3A1-related conditions. This sequence change falls in intron 3 of the COL3A1 gene. It does not directly change the encoded amino acid sequence of the COL3A1 protein, but it affects a nucleotide within the consensus splice site of the intron. |
Ambry Genetics | RCV004031097 | SCV003623087 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-06-30 | criteria provided, single submitter | clinical testing | The c.333+4A>G intronic alteration consists of a A to G substitution nucleotides after coding exon 3 in the COL3A1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |